Omada Health Reports Fourth Quarter and Full-Year 2025 Results Omada Health, Inc. (Nasdaq:

#OMDA Omada Health Reports Fourth Quarter and Full-Year 2025 Results

www.stocktitan.net/news/OMDA/omada-health-r...

Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025 Omada Health (Nasdaq: OMDA) reported preliminary, unaudited revenue for Q4 2025 of $72M–$74M $256M–$258M 886,000 as of December 31, 2025, a 55% increase year-over-year. Results are preliminary and subject to completion of year-end closing procedures and the annual independent audit. Omada plans to release audited Q4 and FY2025 results on March 5, 2026 and will present at the J.P. Morgan Healthcare Conference on January 14, 2026.

#OMDA Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025

www.stocktitan.net/news/OMDA/omada-health-r...

Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss Omada Health (Nasdaq: OMDA) released a 12-month real-world analysis of 965 members in its Enhanced GLP-1 Care Track showing durable weight loss when behavioral support is paired with GLP-1 medications. Members who persisted on medication for 12 months averaged 18.4% weight loss, versus 11.9% in cited real-world evidence; overall program members averaged 16.3% weight loss. Persistence at one year was 67%, higher than the 47–49% comparator. The analysis used pharmacy claims and clinical data and highlights Omada’s prescription and medication-management capability for anti-obesity medications.

#OMDA Omada Health’s GLP-1 Behavior Change Companion Programs Help Drive Lasting, Long-Term Weight Loss

www.stocktitan.net/news/OMDA/omada-health-s...

My Top 20 Holdings in 2026 2026 Top 20 High-Beta Picks for 3x+ Portfolio Growth

2025 portfolio +156% but left cash on the table—can I triple it in 2026 with these 20 high-beta names or will tariffs, Fed drama and AI jitters send me back to square one?
#GOOG #NBIS #Zeta #PATH #TEM #GLUE #RXRX #LQDA #OMDA #LMND #HOOD #TSLA #SYM #TER
open.substack.com/pub/frontier...

Leading Indicators, Wednesday December 3, 2025 – Crystal Equity Research

Small-cap stocks with strong volume declines, Wed Dec 3rd - #ARTL #DEVS #IMRN #LOT #WOK #VS #SONN #POLE #OMDA #IPWR #HCMA #CLNN #BWIN #ACHC #ADCT - More: crystalequityresearch.com/leading-indi... - #smallcap

Omada Health Announces GLP-1 Prescribing Capability to Support Growing Member Population Omada Health (NASDAQ: OMDA) announced a planned nationwide prescribing capability for anti-obesity medications (AOM), including GLP-1s, to integrate medication management into its evidence-based behavior change weight program.The company reported 53% year-over-year member growth through Q3 2025 and said the prescribing option will be available in all 50 states. Omada cited published analyses showing a 28% greater weight loss at 4 months in its Enhanced GLP-1 Care Track and 0.8% average weight change 12 months after discontinuation in one analysis versus 11–12% gain in trials.

#OMDA Omada Health Announces GLP-1 Prescribing Capability to Support Growing Member Population

www.stocktitan.net/news/OMDA/omada-health-a...

Omada Health Reports Third Quarter 2025 Results Omada Health (NASDAQ: OMDA) reported Q3 2025 results: revenue $68.0M (+49% year-over-year) and total members 831,000 (+53% YoY). Gross margin improved to 66% and non-GAAP gross margin to 68%. Omada posted a net loss of $3M versus $9M a year earlier and delivered its first quarter of positive adjusted EBITDA: $2M. Cash and cash equivalents were $199M at September 30, 2025. Management announced a new GLP-1 prescribing offering, launched AI nutrition product Meal Map, and published its 30th peer-reviewed manuscript with weight-maintenance data after GLP-1 discontinuation. Full-year 2025 guidance was raised to $251.5M–$254.5M revenue and adjusted EBITDA of a $2M loss to breakeven.

#OMDA Omada Health Reports Third Quarter 2025 Results

www.stocktitan.net/news/OMDA/omada-health-r...

Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer Omada Health (Nasdaq: OMDA) appointed Thomas Tsang, MD, MPH as Chief Medical Officer on October 27, 2025. Dr. Tsang will lead clinical quality, outcomes, strategy, and innovation across Omada’s multi-condition virtual care platform.He brings prior roles including founding CEO of Valera Health (raised >$75 million; scaled to >500 employees), CMO at Merck Healthcare Services and Solutions, and policy roles at the Office of the National Coordinator and the U.S. House Ways and Means Committee. Omada highlights its GLP-1 Care Track serving over 100,000 members, recent AI launches OmadaSpark and Meal Map, and a customer base exceeding 2,000 organizations.

#OMDA Omada Health Welcomes Thomas Tsang, MD, MPH as Chief Medical Officer

www.stocktitan.net/news/OMDA/omada-health-w...

New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions Omada Health (Nasdaq: OMDA) has released groundbreaking analysis challenging common assumptions about weight regain after GLP-1 medication discontinuation. The study of 816 members showed that 63% of participants maintained or continued losing weight 12 months after stopping GLP-1 medications, with only a 0.8% average weight change compared to typical 11-12% weight gain seen in clinical trials.The analysis tracked outcomes at 6, 9, and 12 months post-discontinuation, demonstrating consistent weight maintenance throughout the year. Omada has supported over 100,000 members taking GLP-1 medications through their GLP-1 Care Track program, which provides behavioral support, dedicated care teams, connected devices, and an AI-enhanced digital experience.

#OMDA New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions

www.stocktitan.net/news/OMDA/new-omada-heal...

New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy Omada Health (Nasdaq: OMDA) has released groundbreaking research demonstrating significant cost savings from their virtual physical therapy program. The study compared virtual PT to in-person physical therapy for musculoskeletal (MSK) conditions using claims data from July 2019 to May 2023.Key findings show that Omada's virtual MSK program achieved median per-member-per-month savings exceeding $100 in the first six months, with median gross MSK savings per member over $1,000 at both six and 12 months. The program delivered a positive ROI of 1.8x at both intervals, while reducing total medical care utilization and MSK-related costs compared to traditional in-person therapy.This research is particularly significant as MSK conditions affect over 50% of U.S. adults and cost the healthcare system more than $420 billion in 2018, surpassing costs for diabetes and heart disease.

#OMDA New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy

www.stocktitan.net/news/OMDA/new-research-f...

Omada Health ($OMDA) is gaining traction as its digital care platform scales chronic and mental health programs with expanding payer & employer partnerships.
Read more 👉 www.valuethemarkets.com/analysis/oma...
#OMDA #DigitalHealth #Telemedicine #ValueTheMarkets

Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks Omada Health (OMDA) has released promising data demonstrating the effectiveness of their GLP-1 companion program in improving medication persistence and weight loss outcomes. The analysis of 1,124 members showed significantly higher persistence rates for GLP-1 medications - 94% through 12 weeks and 84% through 24 weeks, compared to previous real-world studies showing rates between 33-80%. Members who remained on their medication through 24 weeks achieved an average weight loss of 12.1%, compared to 7.4% for those who discontinued early. The program provides targeted support including dose titration guidance, side effect management, nutrition advice, and exercise specialist support. These results suggest Omada's enhanced care track can help patients achieve clinical trial-level outcomes in real-world settings, potentially leading to reduced cardiometabolic disease risk.

#OMDA Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

www.stocktitan.net/news/OMDA/omada-health-s...

#OMDA IPO indicated to open at $23 within the next few minutes.

#OMDA Omada IPO bid now at $23…
After pricing at $19 at the midpoint of the range.

Omada Health getting set for its IPO this morning. #OMDA

Diabetes and obesity virtual counseling provider Omada Health prices IPO at $19 per share, at the low end of range.
#OMDA to begin trading on Nasdaq Friday.

#digitalhealth